Members |
acceptabilityId |
3 Buck shot, device |
Acceptable (foundation metadata concept) |
3 Buck shot, device (qualifier value) |
Preferred (foundation metadata concept) |
3 alpha hydroxycholanic acid |
Acceptable (foundation metadata concept) |
3 alpha, 7 alpha, 12 alpha, Trihydroxycholanic acid |
Acceptable (foundation metadata concept) |
3 alpha, 7 beta dihydroxy-5 beta cholanic acid |
Acceptable (foundation metadata concept) |
3 alpha,12 alpha, dihydroxycholanic acid |
Acceptable (foundation metadata concept) |
3 alpha,7 alpha, dihydroxycholanic acid |
Acceptable (foundation metadata concept) |
3 antigen Hepatitis B recombinant surface only vaccine product |
Preferred (foundation metadata concept) |
3 beta-HSD deficiency |
Acceptable (foundation metadata concept) |
3 beta-Hydroxysteroid dehydrogenase deficiency |
Preferred (foundation metadata concept) |
3 beta-Hydroxysteroid dehydrogenase deficiency (disorder) |
Preferred (foundation metadata concept) |
3 day faecal fat estimation |
Preferred (foundation metadata concept) |
3 day faecal fat estimation |
Acceptable (foundation metadata concept) |
3 day faecal fat estimation (& level) |
Preferred (foundation metadata concept) |
3 day faecal fat estimation (& level) |
Preferred (foundation metadata concept) |
3 day faecal fat estimation (& level) (procedure) |
Preferred (foundation metadata concept) |
3 day faecal fat estimation (& level) (procedure) |
Preferred (foundation metadata concept) |
3 day fecal fat estimation (procedure) |
Preferred (foundation metadata concept) |
3 female babies |
Acceptable (foundation metadata concept) |
3 hourly |
Acceptable (foundation metadata concept) |
3 hours post-dose |
Preferred (foundation metadata concept) |
3 hours post-dose (qualifier value) |
Preferred (foundation metadata concept) |
3 lead electrocardiographic monitoring |
Preferred (foundation metadata concept) |
3 lead electrocardiographic monitoring (procedure) |
Preferred (foundation metadata concept) |
3 level of presenting part in relation to ischial spines |
Preferred (foundation metadata concept) |
3 level of presenting part in relation to ischial spines (finding) |
Preferred (foundation metadata concept) |
3 male babies |
Acceptable (foundation metadata concept) |
3 methoxy 4 hydroxy phenethylamine |
Acceptable (foundation metadata concept) |
3 methoxy 4 hydroxyphenethylamine |
Acceptable (foundation metadata concept) |
3 methoxy 4 hydroxyphenylethylamine |
Acceptable (foundation metadata concept) |
3 methoxydopamine |
Acceptable (foundation metadata concept) |
3 o'clock position |
Preferred (foundation metadata concept) |
3 o'clock position (qualifier value) |
Preferred (foundation metadata concept) |
3 o'clock position on mammogram |
Preferred (foundation metadata concept) |
3 o'clock position on mammogram (finding) |
Preferred (foundation metadata concept) |
3 part fracture |
Preferred (foundation metadata concept) |
3 part fracture (morphologic abnormality) |
Preferred (foundation metadata concept) |
3 pin head fixation device |
Preferred (foundation metadata concept) |
3 pin head fixation device (physical object) |
Preferred (foundation metadata concept) |
3 point swing through gait |
Preferred (foundation metadata concept) |
3 point swing through gait (finding) |
Preferred (foundation metadata concept) |
3 point swing to gait |
Preferred (foundation metadata concept) |
3 point swing to gait (finding) |
Preferred (foundation metadata concept) |
3 serotype |
Preferred (foundation metadata concept) |
3 serotype (qualifier value) |
Preferred (foundation metadata concept) |
3 serotypes |
Acceptable (foundation metadata concept) |
3 times a day, before meals |
Acceptable (foundation metadata concept) |
3 times a day, with meals |
Acceptable (foundation metadata concept) |
3 to 4 times a day |
Acceptable (foundation metadata concept) |
3 toed sloth |
Acceptable (foundation metadata concept) |
3% Acetic acid |
Preferred (foundation metadata concept) |
3% Acetic acid (substance) |
Preferred (foundation metadata concept) |
3',5'-cyclic AMP synthetase |
Acceptable (foundation metadata concept) |
3',5'-cyclic-GMP phosphodiesterase |
Preferred (foundation metadata concept) |
3',5'-cyclic-guanosine monophosphate phosphodiesterase |
Acceptable (foundation metadata concept) |
3',5'-cyclic-guanosine monophosphate phosphodiesterase (substance) |
Preferred (foundation metadata concept) |
3',5'-cyclic-nucleotide phosphodiesterase |
Preferred (foundation metadata concept) |
3',5'-cyclic-nucleotide phosphodiesterase (substance) |
Preferred (foundation metadata concept) |
3',5'-cyclic-nucleotide phosphodiesterase inhibitor |
Preferred (foundation metadata concept) |
3',5'-cyclic-nucleotide phosphodiesterase inhibitor |
Preferred (foundation metadata concept) |
3',5'-cyclic-nucleotide phosphodiesterase inhibitor (disposition) |
Preferred (foundation metadata concept) |
3',5'-cyclic-nucleotide phosphodiesterase inhibitor-containing product |
Preferred (foundation metadata concept) |
3'-deoxyadenosine |
Preferred (foundation metadata concept) |
3'-deoxyadenosine (substance) |
Preferred (foundation metadata concept) |
3'-deoxyadenosine only product |
Preferred (foundation metadata concept) |
3'-deoxyadenosine-containing product |
Preferred (foundation metadata concept) |
3'-deoxynucleotidase |
Acceptable (foundation metadata concept) |
3'-exonuclease |
Acceptable (foundation metadata concept) |
3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase |
Preferred (foundation metadata concept) |
3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase (substance) |
Preferred (foundation metadata concept) |
3'-methylphthalanilic acid |
Acceptable (foundation metadata concept) |
3'-nucleotidase |
Preferred (foundation metadata concept) |
3'-nucleotidase (substance) |
Preferred (foundation metadata concept) |
3'-phosphoadenylylsulfate 3'-phosphatase |
Preferred (foundation metadata concept) |
3'-phosphoadenylylsulfate 3'-phosphatase (substance) |
Preferred (foundation metadata concept) |
3'-phosphoadenylylsulphate 3'-phosphatase |
Acceptable (foundation metadata concept) |
3'5'-cyclic-CMP synthase |
Acceptable (foundation metadata concept) |
3(or 17)-alpha-hydroxysteroid dehydrogenase |
Preferred (foundation metadata concept) |
3(or 17)-alpha-hydroxysteroid dehydrogenase (substance) |
Preferred (foundation metadata concept) |
3+ pitting edema (finding) |
Preferred (foundation metadata concept) |
3+ pitting oedema |
Preferred (foundation metadata concept) |
3,3' 5 triiodothyronine |
Acceptable (foundation metadata concept) |
3,3' T>2< |
Acceptable (foundation metadata concept) |
3,3' diiodothyronine |
Preferred (foundation metadata concept) |
3,3' diiodothyronine (substance) |
Preferred (foundation metadata concept) |
3,3'-diiodothyronine level above reference range |
Preferred (foundation metadata concept) |
3,3'-diiodothyronine level above reference range (finding) |
Preferred (foundation metadata concept) |
3,3'-diiodothyronine level below reference range |
Preferred (foundation metadata concept) |
3,3'-diiodothyronine level below reference range (finding) |
Preferred (foundation metadata concept) |
3,3'-diiodothyronine within reference range |
Preferred (foundation metadata concept) |
3,3'-diiodothyronine within reference range (finding) |
Preferred (foundation metadata concept) |
3,3'-dimethoxybenzidine |
Preferred (foundation metadata concept) |
3,3'-dimethoxybenzidine (substance) |
Preferred (foundation metadata concept) |
3,3-diphosphono-1,2-propanodicarboxylic acid |
Preferred (foundation metadata concept) |
3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) |
Acceptable (foundation metadata concept) |
3,3-diphosphono-1,2-propanodicarboxylic acid (substance) |
Preferred (foundation metadata concept) |
3,4 Methylhippurate |
Preferred (foundation metadata concept) |
3,4 Methylhippurate (substance) |
Preferred (foundation metadata concept) |
3,4,5-trihydroxybenzoic acid |
Preferred (foundation metadata concept) |
3,4,5-trihydroxybenzoic acid (substance) |
Preferred (foundation metadata concept) |
3,4-Dihydroxyphenylalanine |
Acceptable (foundation metadata concept) |